Sign in
CompletedNo phase

Real-time fMRI Neurofeedback in Patients With MCI

Key facts

Who runs it
University of Bern
Where
Switzerland2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
84 people enrolled
Started
1 Jul 2020
Ended
31 Jan 2024
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • real-time fMRI based neurofeedback from the hippocampus
  • real-time fMRI based neurofeedback from another brain area
Record updated
8 May 2024

Who can take part

Age
60 years to 80 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Intact activities of daily living
  • Fluent in German
  • Normal/corrected-to-normal vision
  • Written informed consent

Who cannot take part

  • Psychotropic medication
  • Currently/lifetime drug or alcohol abuse
  • Magnetisable implants
  • Dementia
  • Current/lifetime severe psychiatric or neurological disorder
  • History of seizures
  • Brain damage

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Increased activity in the hippocampus (i.e., hyperactivity) during a fMRI memory task was found in patients with Mild Cognitive Impairment due to Alzheimer's disease (MCI). Those with increased hippocampal activity exhibited elevated clinical progression. Reducing hippocampal hyperactivity with pharmacological treatment reduced hyperactivity and improved memory performance. The investigators of this study will test whether real-time fMRI neurofeedback will also downregulate hippocampal activity and thereby improve memory performance.

The 4 groups in the trial

  • healthy elderly participants receiving feedback from the hippocampusExisting treatment, for comparison

    This group will consist of healthy elderly volunteers, who will receive feedback from their hippocampal activity.

    Treatment: real-time fMRI based neurofeedback from the hippocampus

  • healthy elderly participants receiving feedback from another areaSham treatment, for comparison

    This group will consist of healthy elderly volunteers, who will receive feedback from another brain area.

    Treatment: real-time fMRI based neurofeedback from another brain area

  • patients with MCI receiving feedback from the hippocampusTreatment being tested

    This group will consist of patients with mild cognitive impairment, who will receive feedback from their hippocampal activity.

    Treatment: real-time fMRI based neurofeedback from the hippocampus

  • patients with MCI receiving feedback from another brain areaSham treatment, for comparison

    This group will consist of patients with mild cognitive impairment, who will receive feedback from another brain area.

    Treatment: real-time fMRI based neurofeedback from another brain area

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Targeting Hippocampal Hyperactivity With Real-time Functional MRI Based Neurofeedback in Elderly Individuals With and Without Memory Problems
Publications
Record updated
8 May 2024